JP Morgan Asset Management has reduced its short position in the medical technology company Bonesupport below the disclosure threshold and is therefore no longer a public short seller in the company.
There is subsequently one public short seller in the company. In total, 5.46 percent of the capital is shorted in Bonesupport.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be made public.
